| Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer G Ren, S Baritaki, H Marathe, J Feng, S Park, S Beach, PS Bazeley, ... Cancer research 72 (12), 3091-3104, 2012 | 260 | 2012 |
| Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials B C Potts, M X Albitar, K C Anderson, S Baritaki, C Berkers, B Bonavida, ... Current cancer drug targets 11 (3), 254-284, 2011 | 255 | 2011 |
| Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP … S Baritaki Oncogene, 2009 | 195 | 2009 |
| Current perspectives in cancer immunotherapy T Christofi, S Baritaki, L Falzone, M Libra, A Zaravinos Cancers 11 (10), 1472, 2019 | 188 | 2019 |
| The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit K Lin, S Baritaki, L Militello, G Malaponte, Y Bevelacqua, B Bonavida Genes & cancer 1 (5), 409-420, 2010 | 187 | 2010 |
| Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo-and immunosensitization to apoptosis and inhibition of metastases B Bonavida, S Baritaki, S Huerta-Yepez, MI Vega, D Chatterjee, K Yeung Nitric oxide 19 (2), 152-157, 2008 | 185 | 2008 |
| Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1 S Baritaki, S Huerta-Yepez, T Sakai, DA Spandidos, B Bonavida Molecular cancer therapeutics 6 (4), 1387-1399, 2007 | 183 | 2007 |
| Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry B Bonavida, S Baritaki Nitric oxide 24 (1), 1-7, 2011 | 149 | 2011 |
| Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up … S Baritaki, A Katsman, D Chatterjee, KC Yeung, DA Spandidos, ... The Journal of Immunology 179 (8), 5441-5453, 2007 | 143 | 2007 |
| Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP S Baritaki, S Huerta-Yepez, A Sahakyan, I Karagiannides, K Bakirtzi, ... Cell cycle 9 (24), 4931-4940, 2010 | 131 | 2010 |
| VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix G Soufla, S Sifakis, S Baritaki, A Zafiropoulos, E Koumantakis, ... Cancer letters 221 (1), 105-118, 2005 | 119 | 2005 |
| The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN circuitry B Bonavida, S Baritaki Critical Reviews™ in Oncogenesis 16 (3-4), 2011 | 115 | 2011 |
| Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization S Baritaki, K Yeung, M Palladino, J Berenson, B Bonavida Cancer research 69 (21), 8376-8385, 2009 | 113 | 2009 |
| Overexpression of VEGF and TGF-β1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis … S Baritaki, S Sifakis, S Huerta-Yepez, IK Neonakis, G Soufla, B Bonavida, ... International journal of oncology 31 (1), 69-79, 2007 | 113 | 2007 |
| Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease S Apostolakis, S Baritaki, GE Kochiadakis, NE Igoumenidis, ... Thrombosis research 119 (1), 63-71, 2007 | 112 | 2007 |
| A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-κB signaling pathways in bladder cancer cells LR Zhang, W Chen, X Li FEBS letters 582 (13), 1821-1828, 2008 | 111 | 2008 |
| Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1 S Huerta-Yepez, M Vega, SE Escoto-Chavez, B Murdock, T Sakai, ... Nitric Oxide 20 (1), 39-52, 2009 | 109 | 2009 |
| Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications S Baritaki, S Apostolakis, P Kanellou, MT Dimanche‐Boitrel, ... Advances in cancer research 98, 149-190, 2007 | 94 | 2007 |
| TRAF6 activation in multiple myeloma: a potential therapeutic target H Liu, S Tamashiro, S Baritaki, M Penichet, Y Yu, H Chen, J Berenson, ... Clinical Lymphoma Myeloma and Leukemia 12 (3), 155-163, 2012 | 93 | 2012 |
| Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis … S Baritaki, E Suzuki, K Umezawa, DA Spandidos, J Berenson, TR Daniels, ... The Journal of Immunology 180 (9), 6199-6210, 2008 | 93 | 2008 |
